Practice Essentials
Spasticity is increased, involuntary, velocity-dependent muscle tone that causes resistance to movement. The condition is typically a result of insult to the central nervous system or motor neurons. It may occur as a primary condition such as in degenerative conditions or as a result of secondary causes such as spinal cord injury, trauma to the brain, or inflammatory conditions such as multiple sclerosis.
Signs and symptoms
Typically, the most common sign on exam is resistance to a passive change in a joint angle. It is most commonly noted in the flexor muscles of the upper extremities, the proximal extensor muscles of the lower extremities, and the distal flexor muscles of the lower extremities. As such, depending on the insult, specific patterns may arise that can aide in treatment.
Cerebral palsy
Children with cerebral palsy tend to exhibit one of the following spasticity patterns:
-
Diplegic pattern: Scissoring, crouching, and toe walking
-
Quadriplegic pattern: Diplegic patterning in addition to flexion of the elbow, flexion of the wrist and fingers, adduction of the thumb, and internal rotation, pronation, or adduction of the arms
-
Hemiplegic pattern: Plantar flexion of the ankle, flexion of the knee, adduction of the hip, flexion of the wrist and finger, adduction of the thumb, and flexion, internal rotation, pronation, or adduction of the arms
Equinovarus positioning of the foot is a common posture in the lower extremity, and it can be a major limitation to functional transfers or gait as a child grows older.
Spasticity of the upper extremities
The following patterns present in patients with cerebral palsy, stroke, or traumatic brain injury (TBI): [1]
-
Adduction and internal rotation of the shoulder
-
Flexion of the elbow and wrist
-
Pronation of the forearm
-
Flexion of the fingers and adduction of the thumb
The following flexor patterns can occur in patients with cerebral palsy, MS, or TBI or who have suffered a stroke: [1]
-
Hip adduction and flexion
-
Knee flexion
-
Ankle plantar flexion or equinovarus positioning
The following extensor patterns may be seen in patients following TBI:
-
Knee extension or flexion
-
Equinus and/or valgus ankle
-
Great toe dorsiflexion or excessive toe flexion
See Clinical Presentation for more detail.
Diagnosis
In patients with new-onset spasticity, a thorough history, including family history, and physical examination are crucial. Additional tests such as electromyography for evaluation of motor neuron disease, determination of nerve conduction velocities, or imaging studies of the head, neck, and spine may be useful in eliminating treatable causes of increased tone. [2]
In patients with a previous neurologic insult, a thorough history and physical examination is necessary to rule out any factors that can exacerbate spasticity (eg, medication changes, noxious stimuli, increased intracranial pressure).
Laboratory studies (eg, complete blood count [CBC] and culturing of urine, blood, cerebrospinal fluid) may help to rule out infection.
Spasticity is difficult to quantify, [3] but clinically useful scales include the following:
-
Ashworth Scale/Modified Ashworth: From 0-4 (normal to rigid tone)
-
Physician's Rating Scale: Gait pattern and range of motion assessed
-
Spasm Scale: From 0-4 (no spasms to >10/h)
See Workup for more detail.
Management
Interventions for spasticity may vary from conservative (therapy and splinting) to more aggressive (surgery); most often, a variety of treatments are used at the same time or are employed interchangeably. Treatment options do not need to be used in a stepladder approach and indeed should not be. Current spasticity management options include the following:
-
Preventative measures
-
Positioning/orthotics (including taping, dynamic and static splints, wheelchairs, and standers)
-
Oral medications (such as baclofen and dantrolene) [6]
-
Injectable neurolytic medications (botulinum toxins and phenol)
-
Intrathecal baclofen
-
Surgical intervention (including selective dorsal rhizotomy and orthopedic procedures)
See Treatment and Medication for more detail.
Background
Spasticity is increased, involuntary, velocity-dependent muscle tone that causes resistance to movement. The condition may occur secondary to a disorder or trauma, such as a tumor, a stroke, multiple sclerosis (MS), cerebral palsy, or a spinal cord, brain, or peripheral nerve injury. (See Pathophysiology and Etiology.)
Spasticity usually is accompanied by paresis and other signs, such as increased stretch reflexes, which collectively are called upper motor neuron syndrome. Paresis particularly affects distal muscles, with loss of the ability to perform fractionated movements of the digits. (See Clinical Presentation.)
Upper motor neuron syndrome results from damage to descending motor pathways at the cortical, brainstem, or spinal cord levels. When the injury that leads to spasticity is acute, muscle tone is flaccid with hyporeflexia before the appearance of spasticity. The interval between injury and the appearance of spasticity varies from days to months according to the level of the lesion. In addition to weakness and increased muscle tone, the signs in spasticity include the following (see Clinical Presentation):
-
Clonus
-
Clasp-knife phenomenon
-
Hyperreflexia
-
Babinski sign
-
Flexor reflexes
-
Flexor spasms
Spasticity can be severely debilitating, but with appropriate neurologic, surgical, rehabilitative, and psychosocial interventions, its manifestations can be treated, thus greatly improving the quality of life of affected individuals. (See Prognosis, Treatment, and Medication.)
While the incidence of spasticity is not known with certainty, the condition likely affects over half a million people in the United States and over 12 million people worldwide.
Pathophysiology
The pathophysiologic basis of spasticity is incompletely understood. Polysynaptic responses may be involved in spinal cord–mediated spasticity, while enhanced excitability of monosynaptic pathways is involved in cortically mediated spasticity.
Spasticity-related changes in muscle tone probably result from alterations in the balance of inputs from reticulospinal and other descending pathways to the motor and interneuronal circuits of the spinal cord, along with the absence of an intact corticospinal system. Loss of descending tonic or phasic excitatory and inhibitory inputs to the spinal motor apparatus, alterations in the segmental balance of excitatory and inhibitory control, denervation supersensitivity, and neuronal sprouting may be observed.
Once spasticity is established, the chronically shortened muscle may develop physical changes, such as shortening and contracture, that further contribute to muscle stiffness. [7]
Cortical and spinal cord damage
Selective damage to area 4 in the cerebral cortex of primates produces paresis that improves with time, but increases in muscle tone are not a prominent feature. Lesions involving area 6 cause impairment of postural control in the contralateral limbs. Combined lesions of areas 4 and 6 cause both paresis and spasticity to develop.
Physiologic evidence suggests that interruption of reticulospinal projections is important in the genesis of spasticity. In spinal cord lesions, bilateral damage to the pyramidal and reticulospinal pathways can produce severe spasticity and flexor spasms, reflecting increased tone in flexor muscle groups and weakness of extensor muscles.
Mechanisms of spasticity
The pathophysiologic mechanisms causing the increase in stretch reflexes in spasticity also are not well understood. Unlike healthy subjects, in whom rapid muscle stretch does not elicit reflex muscle activity beyond the normal short-latency tendon reflex, patients with spasticity experience prolonged muscle contraction when spastic muscles are stretched. After an acute injury, the ease with which muscle activity is evoked by stretch increases in the first month of spasticity; then, the threshold remains stable until declining after a year.
During the development of spasticity, the spinal cord undergoes neurophysiologic changes in the excitability of motor neurons, interneuronal connections, and local reflex pathways. The excitability of alpha motor neurons is increased, as is suggested by enhanced H-M ratios [8] and F-wave amplitudes. [9] Judged by recordings from Ia spindle afferents, muscle spindle sensitivity is not increased in human spasticity.
Local anesthetic injections into spastic muscles in man can diminish spasticity through an effect on gamma motor neurons. Renshaw cells receive inputs from descending motor pathways, and recurrent collateral axons from motor neurons activate Renshaw cells, which inhibit gamma motor neurons. Renshaw cell activity is not reduced significantly in spasticity.
Reciprocal inhibition between antagonist muscles is mediated by the Ia inhibitory interneuron, which also receives input from descending pathways. Altered activity in Ia pathways has been shown in spasticity. Inhibitory interneurons acting on primary afferent terminals of the alpha motor neuron also influence the local circuitry.
Finally, plasticity and the formation of new aberrant connections in the central nervous system (CNS) is another theoretical explanation for some of the events in spasticity.
Etiology
Treatable factors that may cause sudden onset of spasticity include the following:
-
Tethered spinal cord
-
Nerve impingement peripherally or centrally
-
Hydrocephalus
-
Intracranial, epidural, or subdural bleeding
Factors that can exacerbate preexisting spasticity from spinal injury, brain tumor/injury, cerebral palsy, or MS include the following:
-
Infection (eg, otitis, urinary tract infection, pneumonia)
-
Noxious stimulus (eg, ingrown toenail, ill-fitting orthotics, occult fracture)
-
Bladder distention
-
Bowel impaction
-
Cold weather
-
Fatigue
-
Seizure activity
-
Stress
-
Malpositioning
Prognosis
Spasticity can have a devastating effect on function, comfort, and care delivery, and it also may lead to musculoskeletal complications. Spasticity does not always require treatment, but when it does, a wide range of effective therapies—used alone or in combination—are available.
Multiple sclerosis
Rizzo et al, in an analysis of a cross-sectional database of 17,501 patients with MS (NARCOMS registry), reported the following with regard to the prevalence of spasticity [10] :
-
15.7% had no spasticity
-
50.3% had minimal to mild spasticity
-
17.2% had moderate spasticity
-
16.8% had severe spasticity
Stroke
In several studies examining patients at 12 months post-stroke, spasticity has been estimated to occur in up to 46% of patients 12 months after stroke. [11, 12, 13] Spasticity is associated with a negative impact on the health-related quality of life (HRQoL) of stroke survivors with statistically and clinically meaningful differences existing between stroke survivors with and without spasticity. These results suggest an opportunity to improve HRQoL among stroke survivors with spasticity. [1]
Disadvantages of spasticity
The negative impacts of spasticity on health and quality of life include the following:
-
Orthopedic deformity, such as hip dislocation, contractures, or scoliosis
-
Impairment of activities of daily living (eg, dressing, bathing, toileting)
-
Impairment of mobility (eg, inability to walk, roll, sit)
-
Skin breakdown secondary to positioning difficulties and shearing pressure
-
Pain or abnormal sensory feedback
-
Poor weight gain secondary to high caloric expenditure
-
Sleep disturbance
-
Depression secondary to lack of functional independence
Advantages of spasticity
Spasticity can confer certain benefits to the patient, including the following:
-
Substitutes for strength, allowing standing, walking, gripping
-
May improve circulation and prevent deep venous thrombosis and edema
-
May reduce the risk of osteoporosis
Patient Education
Resources and advocacy groups
Christopher & Dana Reeve Foundation
636 Morris Turnpike
Suite 3A
Short Hills, NJ 07078, USA
TEL: (800) 225-0292 or
(973) 379-2690 (outside the United States)
American Stroke Association, a division of the American Heart Association
7272 Greenville Avenue
Dallas, TX 75231, USA
TEL: (888) 478-7653
Brain Injury Association of America
1608 Spring Hill Road
Suite 110
Vienna, VA 22182, USA
TEL: (703) 761-0750
Email: info@biausa.org
Multiple Sclerosis Association of America
706 Haddonfield Road
Cherry Hill, NJ 08002, USA
TEL: (800) 532-7667 or (856) 488-4500
FAX: (856) 661-9797
Email: webmaster@mymsaa.org (general information) or MSquestions@mymsaa.org (MS questions)
6520 N Andrews Avenue
Ft Lauderdale, FL 33309-2130, USA
TEL: (888) 673-6287 or (954) 776-6805
FAX: (954) 351-0630
Email: support@msfocus.org
National Multiple Sclerosis Society
733 3rd Avenue, 6th Floor
New York, NY 10017-3288, USA
TEL: (800) FIGHT MS (344-4867) or (212) 986-3240
FAX: (212) 986-7981
Email: info@nmss.org
National Spinal Cord Injury Association
A program of the United Spinal Association
75-20 Astoria Blvd
Jackson Heights, NY 11370, USA
TEL: (718) 803-3782
9707 East Easter Lane
Suite B
Centennial, CO 80112, USA
TEL: (800) 787-6537
FAX: (303) 649-1328
Stroke Clubs International
Contact: Ellis Williamson
805 12th Street
Galveston, TX 77550, USA
TEL: (409) 762-1022
Email: strokeclub@aol.com
1825 K Street NW
Suite 600
Washington, DC 20006, USA
TEL: (800) 872-5827 or (202) 776-0406